Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in

MLA

Bernardo H L, Goulart, et al. “Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes In.” JCO Oncology Practice, vol. 17, no. 2, Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8811347239268e843f4eba4bfa2435e0&authtype=sso&custid=ns315887.

APA

Bernardo H L, G., Joseph M, U., Shasank, C., Catherine R, F., & Scott D, R. (2020). Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in. JCO Oncology Practice, 17(2).

Chicago

Bernardo H L, Goulart, Unger Joseph M, Chennupati Shasank, Fedorenko Catherine R, and Ramsey Scott D. 2020. “Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes In.” JCO Oncology Practice 17 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8811347239268e843f4eba4bfa2435e0&authtype=sso&custid=ns315887.